SCHEDULE: Frazier Life Sciences Amends Savara Inc. Stake
Beneficial Ownership Amendment
Frazier Life Sciences and affiliated entities filed an amended Schedule 13G, clarifying their beneficial ownership of Savara Inc. common stock.
Summary
- Frazier Life Sciences Public Fund, L.P. and its related entities beneficially own 6,745,296 shares, representing 3.9% of Savara Inc.'s common stock.
- Frazier Life Sciences Public Overage Fund, L.P. and its related entities beneficially own 2,889,469 shares, representing 1.7% of Savara Inc.'s common stock.
- Frazier Life Sciences X, L.P. and its related entities beneficially own 324,346 shares, representing 0.2% of Savara Inc.'s common stock.
- Frazier Life Sciences XI, L.P. and its related entities beneficially own 1,503,190 shares, representing 0.9% of Savara Inc.'s common stock.
- The total aggregate beneficial ownership by the Frazier Life Sciences group is 11,462,301 shares, representing approximately 6.7% of Savara Inc.'s common stock.
- The filing clarifies that members of the investment committees for Frazier Life Sciences Public Fund, L.P., Frazier Life Sciences Public Overage Fund, L.P., and Frazier Life Sciences XI, L.P. are not attributed beneficial ownership of the securities directly held by these funds, correcting previous overstatements.
- Beneficial ownership percentages are calculated based on 172,836,922 shares of Common Stock outstanding as of May 13, 2025.
Sentiment
Score: 5
Explanation: This is a factual amendment to a beneficial ownership report, providing clarity on ownership attribution rather than indicating any positive or negative operational or financial developments for the company.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Beneficial Ownership Attribution Clarification | The filing clarifies that members of the investment committees for Frazier Life Sciences Public Fund, L.P., Frazier Life Sciences Public Overage Fund, L.P., and Frazier Life Sciences XI, L.P. are not attributed beneficial ownership of the securities directly held by these funds. This corrects previous overstatements of beneficial ownership by these individuals. | 2025-06-30 | Enhances transparency regarding the precise beneficial ownership structure and control within the Frazier Life Sciences group, clarifying which entities and individuals hold voting and dispositive power over Savara Inc. shares. |
Stakeholder Impact
- Shareholders: Provides clearer understanding of the beneficial ownership structure of a significant institutional investor group, clarifying who holds voting and dispositive power.
Key Dates
| Date | Description |
|---|---|
| 2025-05-13 | Date of Savara Inc.'s Quarterly Report on Form 10-Q, which stated 172,836,922 shares of Common Stock outstanding. |
| 2025-06-30 | Date of event which requires filing of this statement (reporting period end date for ownership calculation). |
| 2025-08-14 | Filing date of this Schedule 13G Amendment No. 2. |
Keywords
Savara Inc., Frazier Life Sciences, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.